First human doses given in early drug safety trial
NCT ID NCT07035769
Summary
This is a very early-stage study to check the safety and see how a new oral drug, Debio 1453P, moves through the body of healthy adults. The main goal is to find out what side effects might occur and how the body absorbs and eliminates the drug at different dose levels. It does not aim to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
SGS Belgium NV - Clinical Pharmacology Unit
RECRUITINGEdegem, 2650, Belgium
Conditions
Explore the condition pages connected to this study.